| abstract |
In general, among other things, compounds of Formula I are provided: n n n n n n n n n n in which R 11 is e.g., 4-(pyrrolidin-1-yl)piperidin-1-yl, N-methyl-3-(pyrrolidin-1-yl)propan-1-amino, N 1 ,N 1 ,N 3 -trimethylpropane-1,3-diamino, N,N-dimethylpiperidin-4-amino, 3-(pyrrolidin-1-ylmethyl)azetidin-1-yl, 3-(pyrrolidin-1-ylmethanon)azetidin-1-yl, or 3-(morpholin-1-ylmethyl)azetidin-1-yl; R 13 is, e.g., phenyl optionally substituted with one or more substituents; and R 12 and R 14 are each independently hydrogen or alkyl. Methods of treatment are also provided. |